| Literature DB >> 22152042 |
Indu Barwal1, Peeyush Ranjan, Suneel Kateriya, Subhash Chandra Yadav.
Abstract
BACKGROUND: Elucidation of molecular mechanism of silver nanoparticles (SNPs) biosynthesis is important to control its size, shape and monodispersity. The evaluation of molecular mechanism of biosynthesis of SNPs is of prime importance for the commercialization and methodology development for controlling the shape and size (uniform distribution) of SNPs. The unicellular algae Chlamydomonas reinhardtii was exploited as a model system to elucidate the role of cellular proteins in SNPs biosynthesis.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22152042 PMCID: PMC3283517 DOI: 10.1186/1477-3155-9-56
Source DB: PubMed Journal: J Nanobiotechnology ISSN: 1477-3155 Impact factor: 10.435
Figure 1Kinetics of biosynthesis of silver nanoparticles (a) Synthesis of nanoparticles in C. reinhardtii cell free extracts (in vitro) system and (b) in vivo condition. The color of the C. reinhardtii cell becomes yellowish brown after incubation with 1 mM AgNO3 in 5 hours (inset). (c) ICP-MS quantification of remaining Ag+ (in ppm) after removal of in vivo biosynthesized SNPs.
Figure 2Morphological characterization of the silver nanoparticles. (a) In vitro synthesis, diffraction pattern, and EDAX analysis was given in inset (b) In vivo synthesis and its diffraction pattern (inset) (c) TEM high resolution Image (HR Image) of C. reinhardtii cell mediated synthesized silver nanoparticles and (d) Magnified view of SNPs fringes and Fourier transform image in inset.
Figure 3Cellular localization of (a) TEM micrograph of thin section (~60 nm) and (b) SEM image of 1 mM AgNO3 incubated C. reinhardtii cell. (c) Silver nanoparticles localized on the flagellum.
Figure 4Total protein depletion experiments of (a) Synthesis kinetics of SNPs by C. reinhardtii cell free extract (●), DEAE-sepharose (▼), CM-sepharose (○) depleted flow through samples (b) The absorbance scans of C. reinhardtii cell free extract, DEAE-sepharose and CM-sepharose depleted flow through samples after silver nanoparticles synthesis.
Figure 5Morphological characterization of protein depleted synthesized SNPs (a) C. reinhardtii cell free extract, (b) DEAE-sepharose and (c) CM-sepharose depleted flow through solution synthesized SNPs.
Figure 6Cellular protein profiling of biosynthesized SNPs. Biosynthesized silver nanoparticles were gently washed (DW) and equal amount of bound proteins were loaded on reducing SDS-PAGE. The freshly synthesized silver nanoparticles (protein and surfactant free) were incubated with C. reinhardtii cell free extracts for three days. (a) Molecular weight marker (lane no 1), crude extract (lane no 2) and supernatant after nanoparticles synthesis (lane no 3). (b) Silver nanoparticles bound protein after 4 days (lane no 4), 7 days (lane no 5) and 12 days (lane no 6) incubation at reaction condition. (c) Protein binding on pre-synthesized silver nanoparticles of increasing amount 40 μl (lane7), 70 μl (lane 8) and 100 μl (lane 9). The washed isolated nanoparticles were subjected for SDS-PAGE analysis with different increasing volume.
MALDI-TOF-TOF of various SNPs associated proteins with matched sequences
| Protein Name | MW | Coverage (%) | Peptide | Full proteins Sequence (Matched peptides bold underlined) | |
|---|---|---|---|---|---|
| 1 | Histone H4 | 11.4 | 19.4 | R.ISGLIYEETR.T; K.TFLENVIR.D; R.DNIQGITKPAIR.R; K.RISGLIYEETR.T | MSGRGKGGKGLGKGGAKRHRKVL |
| 2 | Carbonic anhydrase | 41.6 | 42.8 | K.QSPINVPQYQVLDGK.G; R.IVDVLEMRPNDAADR.V | CIYKFGTSPDS |
| 3 | Ferredoxin--NADP reductase | 39.2 | 8.4 | K.VLLLPADANAPLICVATGTGIAPFR.S | AATKASTAVTTDMSKRTVPTKLEEGEMPLNTYSNKAPFKAKVRSVEKITGPKATGETCHIIIETEGKIPFWEGQSYGVIPPGTKINSKGKEVPTARLYSIASSRYGDDGDGQTASLCVRRAVYVDPETGKEDPAKKGLCSNFLCDATPGTEISMTGPTG |
| 4 | Superoxide dismutase | 23.9 | 10.1 | R.RPEYIAAWWNVVNWEQVAENYK.A | MAQALPPLPYDYGSLEPHVDATTMNIHHTKHHQTYVNNLNAALDKFPELKDLGLVDLNKAVGTDKLPKDVATVIRNNGGGHYNHSFFWKVMTNPSNTNGPNGDVKAAIEASFGSVDEMKAKFNAAAAGRFGSGWAWLSVKPDGSLSIDSTPNQDNPLMTALPDVAGGIPLLGLDVWEHAYYLKYQNR |
| 5 | Sedoheptulose-1,7-bisphosphatase | 41.7 | 21.8 | R.ATFDNPAYER.L | RAARVQSRRTAVLTQAKIGDSLAEFLVEATPDPKLRHVMMSMAEATRTIAHKVRTASCAGTACVNSFGDEQLAVDMVADKLLFEALKYSHVCKLACSEEVPEPVDMGGEGFCVAFDPLDGSSSSDTNFAVGTIFGVWPGDKLTNITG |
| 6 | ATP synthase subunit alpha | 54.7 | 53.5 | K.MVDFGIVFQVGDGIAR.I; K.IAEIPVGEAYLGR.V | MAM |
| 7 | ATP synthase subunit beta | 52.0 | 30.9 | K.GQVPNIYNALTIR.A; R.TAPAFVDLDTRLSIFETGIK.V | MSDSIETKNMGRIVQIIGPVLDIVFA |
| 8 | ATP synthase gamma chain | 38.7 | 15.0 | K.VLYGVNQR.V; R.SLQEALASELAAR.M | MAAMLASKQGAFMGRSSFAPAPKGVASRGSLQVVAGLKEVRDRIASVKNTQKITDAMKLVAAAKVR |
| 9 | Oxygen evolving enhancer protein (OEE)1 | 30.5 | 20.8 | R.VAFLFTIK.Q | LTFDEIQGLTYLQVKGSGIANTCPVLESGTTNLKELKAGSYKLENFCIEPTSFTVKEESQFKGGETEFVKTKLMTRLTYTLDAMSGSF |
| 10 | OEE2 | 25.8 | 25.5 | K.WNPSKENDFPGVILR.Y; K.ENDFPGVILR.Y | AYGDSANVFGKVTNKSGFVPYAGDGFALLLPA |
| 11 | OEE-3 | 21.8 | 25.6 | K.EFIQAVEDLDFALR.E; R.DRGFDLIYEAR.D | LTPVDLFDDRSV |
| 12 | Ribulose bisphosphate carboxylase | 52.5 | 2.5 | R.FLFVAEAIYK.A | TKAGAGFKAGVKDYRLTYYTPDYVVRDTDILAAFRMTPQLGVPPEECGAAVAAESSTGTWTTVWTDGLTSLDRYKGRCYDIEPVPGEDNQYIAYVAYPIDLFEEGSVTNMFTSIVGNVFGFKALRALRLEDLRIPPAYVKTFVGPPHGIQVERDKLNKYGRGLLGCTIKPKLGLSAKNYGRAVYECLRGGLDFTKDDENVNSQPFMRWRD |
| 13 | RuBisCO (SC) | 20.6 | 39.3 | K.AYVSNESAIR.F; R.FGSVSCLYYDNR.Y | MMVWTPVNNKMFETFSYLPPLTDEQIAAQVDYIVANGWIPCLEFAEAD |